Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Change in Accured Expenses (2017 - 2025)

Historic Change in Accured Expenses for Sensus Healthcare (SRTS) over the last 9 years, with Q3 2025 value amounting to $254000.0.

  • Sensus Healthcare's Change in Accured Expenses fell 6313.5% to $254000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 643076.92%. This contributed to the annual value of $2.0 million for FY2024, which is 17397.36% up from last year.
  • As of Q3 2025, Sensus Healthcare's Change in Accured Expenses stood at $254000.0, which was down 6313.5% from -$270000.0 recorded in Q2 2025.
  • Over the past 5 years, Sensus Healthcare's Change in Accured Expenses peaked at $1.3 million during Q4 2021, and registered a low of -$1.2 million during Q4 2023.
  • Moreover, its 5-year median value for Change in Accured Expenses was $167000.0 (2022), whereas its average is $97842.1.
  • Per our database at Business Quant, Sensus Healthcare's Change in Accured Expenses plummeted by 37416.67% in 2023 and then skyrocketed by 108793.1% in 2024.
  • Over the past 5 years, Sensus Healthcare's Change in Accured Expenses (Quarter) stood at $1.3 million in 2021, then plummeted by 51.11% to $638000.0 in 2022, then tumbled by 289.03% to -$1.2 million in 2023, then skyrocketed by 169.49% to $838000.0 in 2024, then plummeted by 69.69% to $254000.0 in 2025.
  • Its Change in Accured Expenses stands at $254000.0 for Q3 2025, versus -$270000.0 for Q2 2025 and $824000.0 for Q1 2025.